Within pretreatment tumors, TIM-3 expression was similarly distributed in patients with adenocarcinoma and squamous cell carcinoma (Fig. 3C and D); however, TIM-3 expression was significantly greater for patients with a PR or SD compared with patients with progressive disease. This evidence concerns the gene HAVCR2 and squamous cell carcinoma.